Dinesh V. Patel, Ph.D.

Dinesh V. Patel, Ph.D.

President and Chief Executive OfficeratProtagonist Therapeutics· In proxies 2022–2025

Pay in FY2025+36% from the year before · Protagonist Therapeutics stock +126.3% the same year

Dinesh V. Patel, Ph.D. was paid $12.9M in FY2025 (Dec), up 36%. Protagonist Therapeutics stock rose 126.3% that year.

Pay$100 in the stock at the end of FY21 → $255
Pay is from the Summary Compensation Table of each Protagonist Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Protagonist TherapeuticsPublic company · 4 yr
    • President and Chief Executive Officer2022 – Present · 4 yrStock in role +316%
  2. Sai Life Sciences, LimitedPublic company · 1 yr
    • Director2025 – Present · 1 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?